Use of dhea in a patient with advanced prostate cancer: A case report and review (Q41645779)

6 October 2017

1 reference

title

Use of DHEA in a patient with advanced prostate cancer: a case report and review (English)

1 reference

6 October 2017

Use of dhea in a patient with advanced prostate cancer: A case report and review (English)

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(97)00395-6

24 November 2024

J. A. Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9372895

24 November 2024

A. Nguyen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9372895

24 November 2024

M. Straub

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9372895

24 November 2024

R. B. Leidich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9372895

24 November 2024

R. L. Veech

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9372895

24 November 2024

S. Wolf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9372895

24 November 2024

language of work or name

English

0 references

publication date

1 November 1997

1 reference

6 October 2017

November 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9372895

full work available at URL

24 November 2024

https://api.elsevier.com/content/article/PII:S0090429597003956?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(97)00395-6

https://api.elsevier.com/content/article/PII:S0090429597003956?httpAccept=text/plain

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(97)00395-6

24 November 2024

1 reference

6 October 2017

1 reference

6 October 2017

1 reference

6 October 2017

page(s)

784-788

1 reference

Inhibition of tumor development by dehydroepiandrosterone and related steroids

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Inhibition of proteinuria development in aging Sprague-Dawley rats and C57BL/6 mice by long-term treatment with dehydroepiandrosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Effects of adrenal androgens on the transplantable human prostate tumor PC-82.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Inhibition of growth of HeLa and WI-38 cells by dehydroepiandrosterone and its reversal by ribo- and deoxyribonucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Aminoglutethimide therapy for advanced carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

SUPPRESSION OF PLASMA ANDROGENS BY THE ANTIANDROGEN FLUTAMIDE IN PROSTATIC CANCER PATIENTS TREATED WITH ZOLADEX, A GnRH ANALOGUE

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Effect of High-dose Medroxyprogesterone Acetate on Plasma Hormone Levels and Pain Relief in Patients with Advanced Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Effects of high dose ketoconazole therapy on the main plasma testicular and adrenal steroids in previously untreated prostatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Ketoconazole therapy in advanced prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

Effect of Suramin on Human Prostate Cancer Cells in Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

1 reference

7 January 2021

Androgens, adrenal androgen precursors, and their metabolism in untreated primary tumors and lymph node metastases of human prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900395-6

7 January 2021

The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(97)00395-6

Hormonal Effects on Cell Proliferation in Rat Prostate

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(97)00395-6

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(97)00395-6

Steroid synthesis inhibition by ketoconazole: sites of action

24 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0090-4295(97)00395-6

24 November 2024

Identifiers

1 reference

6 October 2017

1 reference